Catalent | Ventes



Ventes Changement Date
Agilent USD 1.86B 123M 2025-09
AstraZeneca USD 15.5B 313M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Centene USD 49.73B 40M 2025-12
Charles River Laboratories USD 1000M 32.14M 2025-09
Cigna USD 72.47B 2.77B 2025-12
Danaher USD 6.84B 790M 2025-12
Dentsply International USD 904M 32M 2025-09
Elevance Health USD 49.3B 790M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Hologic USD 1.05B 0 2025-12
Humana USD 32.52B 130M 2025-12
Illumina USD 1.16B 80M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
J&J USD 24.6B 610M 2025-12
Laboratory Of America USD 3.56B 30M 2025-09
Lonza CHF 3.58B 63M 2025-06
McKesson USD 106.16B 3.01B 2025-12
Merck EUR 5.32B 890M 2025-09
Merck USD 16.4B 880M 2025-12
Mettler Toledo International USD 1.13B 100M 2025-12
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
Quest Diagnostics USD 2.81B 10M 2025-12
Repligen USD 189M 7M 2025-09
Revvity USD 772.06M 73.06M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Supernus Pharmaceuticals USD 192.1M 26.6M 2025-09
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
UnitedHealth USD 113.2B 0 2025-12
Waters USD 932M 132M 2025-12
West Pharmaceutical Services USD 805M 400K 2025-12


Catalent Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.